Target Price | $181.89 |
Price | $159.14 |
Potential |
14.30%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target TransMedics Group, Inc. 2025 .
The average TransMedics Group, Inc. target price is $181.89.
This is
14.30%
register free of charge
$208.00
30.70%
register free of charge
$153.00
3.86%
register free of charge
|
|
A rating was issued by 10 analysts: 9 Analysts recommend TransMedics Group, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the TransMedics Group, Inc. stock has an average upside potential 2025 of
14.30%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 241.62 | 444.36 |
158.53% | 83.91% | |
EBITDA Margin | 3.63% | 17.64% |
112.44% | 386.55% | |
Net Margin | -10.62% | 9.11% |
75.79% | 185.82% |
10 Analysts have issued a sales forecast TransMedics Group, Inc. 2024 . The average TransMedics Group, Inc. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an TransMedics Group, Inc. EBITDA forecast 2024. The average TransMedics Group, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 TransMedics Group, Inc. Analysts have issued a net profit forecast 2024. The average TransMedics Group, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.77 | 1.22 |
37.40% | 258.44% | |
P/E | 130.98 | |
EV/Sales | 12.29 |
6 Analysts have issued a TransMedics Group, Inc. forecast for earnings per share. The average TransMedics Group, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the TransMedics Group, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
TransMedics Group, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.